Skip to Content

Weekly Drug News Round Up - September 30, 2015

Two New Insulins Win FDA Approval for Diabetes

Roughly 21 million people in the US have diabetes Read More...

This month, the U.S. Food and Drug Administration (FDA) approved two new insulins from Novo Nordisk: Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar (glucose) control in adults with diabetes. Tresiba is a long-acting insulin injected once daily, while Ryzodeg is a mixture of long-acting and rapid-acting insulin analogs. Both products are approved for type 1 and type 2 diabetes. Some of the most common side effects with Tresiba and Ryzodeg include low blood sugar, allergic reactions, injection site reactions, and weight gain.

Betaconnect Electronic Autoinjector Developed for Multiple Sclerosis

According to Bayer Healthcare, Betaconnect will be available to Betaseron patients at no additional cost Read More...

The U.S. Food and Drug Administration (FDA) has approved Betaconnect, an electronic autoinjector for the treatment of relapsing-remitting multiple sclerosis (RRMS). The new autoinjector offers customizable injection speed and depth settings that allow patients to inject, but patients should speak to their healthcare provider before making any injection changes. Injection depths include 8, 10, and 12 millimeters. Betaconnect also has an optional reminder function that alerts when it's time for the next injection. Additionally, a visual and audio end-of-dose indication lets patients know when the injection is complete. Betaconnect will be available exclusively to Betaseron (interferon beta-1b) patients beginning in early 2016.

Aspirin Use Linked With Longer Survival in Gastrointestinal Cancers: Study

You shouldn't start taking a daily aspirin therapy on your own without talking to your doctor first due to a bleeding risk Read More...

Millions of American use daily low-dose aspirin to help prevent heart attacks and stroke, but now research suggests that there may be an added use; aspirin might extend survival for patients fighting cancers of gastrointestinal tract. Researchers looked back at patients with cancers such as colon, rectum and esophagus, and about 28 percent of the patients survived for at least five years. However, people who took daily low-dose aspirin after their diagnosis were twice as likely to survive as those who did not. Researchers cautioned that it's not clear from this study if using aspirin prevents these cancers, only that those taking aspirin is tied to better survival.

Should You Be Taking Your Blood Pressure Medicine at Bedtime?

Always check with your doctor before altering any medication regimen Read More...

Do you take your blood pressure medicine in the morning, or sporadically each day whenever you remember? A new study suggests that taking the medication right before bed may lower the risk for contracting type 2 diabetes by more than half. Hormones such as adrenaline and angiotensin play a role in the development of both high blood pressure and type 2 diabetes. Taking drugs that target these compounds such as angiotensin receptor blockers (ARBs), ACE inhibitors and beta blockers are associated with a reduced risk of diabetes when taken at bedtime. In fact, the risk of developing type 2 diabetes was 57 percent lower in this study.

Starting Hormone Therapy Earlier In Menopause May Have Heart Benefits

For over a decade, experts have been advising limited use of hormone therapy, and that is still the case Read More...

Another study this week reports on timing of medication. Today, hormone therapy is usually considered an option only for women with more severe menopausal symptoms. However, a new study suggests that women who start taking hormone replacement therapy (HRT) closer to the beginning of menopause had a lower risk for heart disease. A large study from Sweden found that those who started HRT within five years of beginning menopause typically stayed free of heart disease for a longer time than non-users. In contrast, women who started HRT later showed an increase in their heart disease risk.